Sulfated Pelvetia siliquosa Polysaccharides Attenuate Pyroptosis via NF-κB Pathway Inhibition Against Calcium Oxalate Stone Formation
Xin-Yi Tong, Xue-Wu Chen, Jia-Yi Zhang, Jian-Ming Ouyang

TL;DR
This study shows that sulfated polysaccharides from Pelvetia siliquosa reduce kidney stone formation by inhibiting cell death and inflammation.
Contribution
The novel finding is that sulfated Pelvetia siliquosa polysaccharides inhibit pyroptosis and NF-κB pathways to prevent calcium oxalate stone formation.
Findings
Sulfated polysaccharides reduced pyroptosis in HK-2 cells by up to 6.35%.
PSP3 showed higher protection efficiency than PSP0 due to increased sulfation.
Polysaccharides inhibited NLRP3/ASC/caspase-1/IL-1β pathways and reduced crystal adhesion.
Abstract
Objective: The formation of calcium oxalate (CaOx) kidney stones is accompanied by the pyroptosis of renal epithelial cells. The risk of kidney stone formation can possibly be reduced through pyroptosis inhibition. Methods: Pyroptosis of HK-2 cells induced by 3 µm CaOx monohydrate (COM-3 µm) was inhibited by Pelvetia siliquosa polysaccharides before and after sulfation (PSP0 and PSP3, with −OSO3− contents of 1.04% and 36.12%, respectively). The inhibitory efficiency and mechanism of PSP0 and PSP3 were evaluated via caspase-1/PI double staining and Western blot detection of pathway proteins in pyroptosis cells. The potential anti-stone effect of polysaccharides was evaluated through measurement of the extent of crystal adhesion on the cell surface. Results: The proportion of pyroptosis cells induced by COM-3 µm reached 17.87%. After protection by PSP0 and PSP3, the percentage of…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsKidney Stones and Urolithiasis Treatments · Inflammasome and immune disorders · Gout, Hyperuricemia, Uric Acid
